US Stock MarketDetailed Quotes
LUMO Lumos Pharma
- 4.400
- -0.015-0.34%
Trading Nov 5 09:52 ET
38.05MMarket Cap-995P/E (TTM)
4.450High4.400Low4.02KVolume4.450Open4.415Pre Close17.69KTurnover0.07%Turnover RatioLossP/E (Static)8.65MShares4.57652wk High3.70P/B25.71MFloat Cap1.37052wk Low--Dividend TTM5.84MShs Float36.720Historical High--Div YieldTTM1.13%Amplitude1.370Historical Low4.405Avg Price1Lot Size
Lumos Pharma Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -66.96%16.8M | -60.02%23.18M | -46.44%36.08M | -46.44%36.08M | -42.04%42.69M | -36.05%50.85M | -33.17%57.98M | -28.95%67.36M | -28.95%67.36M | -26.81%73.67M |
| -Cash and cash equivalents | -55.63%16.8M | -47.37%23.18M | -37.37%35.08M | -37.37%35.08M | -51.73%35.56M | -52.38%37.86M | -49.24%44.04M | -40.93%56.01M | -40.93%56.01M | -26.81%73.67M |
| -Short-term investments | --0 | --0 | -91.20%999K | -91.20%999K | --7.14M | --12.99M | --13.95M | --11.35M | --11.35M | ---- |
| Receivables | -27.90%168K | -9.50%181K | -5.83%210K | -5.83%210K | 2.38%172K | 56.38%233K | 49.25%200K | 74.22%223K | 74.22%223K | 44.83%168K |
| -Taxes receivable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 44.83%168K |
| -Other receivables | -27.90%168K | -9.50%181K | -5.83%210K | -5.83%210K | --172K | --233K | --200K | 74.22%223K | 74.22%223K | ---- |
| Other current assets | -19.88%3.93M | -17.48%4.18M | -15.34%3.75M | -15.34%3.75M | -8.34%4.58M | -8.05%4.9M | -11.87%5.07M | -6.60%4.43M | -6.60%4.43M | 0.20%5M |
| Total current assets | -62.68%20.89M | -56.45%27.54M | -44.40%40.04M | -44.40%40.04M | -39.81%47.45M | -34.13%55.98M | -31.73%63.25M | -27.76%72.01M | -27.76%72.01M | -25.46%78.83M |
| Non current assets | ||||||||||
| Net PPE | 18.72%463K | 13.14%534K | 113.07%603K | 113.07%603K | -19.36%304K | -16.13%390K | -13.39%472K | -55.43%283K | -55.43%283K | -46.98%377K |
| -Gross PPE | 18.72%463K | 13.14%534K | 113.07%603K | 113.07%603K | -19.36%304K | -16.13%390K | -13.39%472K | -55.43%283K | -55.43%283K | -46.98%377K |
| Total non current assets | 18.72%463K | 13.14%534K | 113.07%603K | 113.07%603K | -19.36%304K | -16.13%390K | -13.39%472K | -55.43%283K | -55.43%283K | -46.98%377K |
| Total assets | -62.12%21.36M | -55.94%28.08M | -43.79%40.64M | -43.79%40.64M | -39.72%47.75M | -34.03%56.37M | -31.62%63.73M | -27.93%72.29M | -27.93%72.29M | -25.60%79.21M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | 20.79%337K | -32.02%569K | 223.64%890K | 223.64%890K | -31.27%488K | -67.33%279K | -53.47%837K | -55.07%275K | -55.07%275K | 376.51%710K |
| -accounts payable | 20.79%337K | -32.02%569K | 223.64%890K | 223.64%890K | -31.27%488K | -67.33%279K | -53.47%837K | -55.07%275K | -55.07%275K | 376.51%710K |
| Current accrued expenses | -51.03%1.79M | -22.78%1.8M | -3.44%2.39M | -3.44%2.39M | 42.67%2.7M | 141.98%3.65M | 44.16%2.33M | 82.50%2.47M | 82.50%2.47M | -65.99%1.89M |
| Current debt and capital lease obligation | 69.83%304K | 26.29%293K | 21.03%282K | 21.03%282K | -57.14%126K | -44.06%179K | -32.75%232K | -33.81%233K | -33.81%233K | -15.76%294K |
| -Current capital lease obligation | 69.83%304K | 26.29%293K | 21.03%282K | 21.03%282K | -57.14%126K | -44.06%179K | -32.75%232K | -33.81%233K | -33.81%233K | -15.76%294K |
| Current liabilities | -24.60%4.94M | -12.02%4.41M | 4.80%7.03M | 4.80%7.03M | 11.54%6.12M | 35.45%6.55M | -4.29%5.02M | 30.76%6.71M | 30.76%6.71M | -9.42%5.48M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | -13.17%145K | 19.05%225K | --303K | --303K | 652.63%143K | 122.67%167K | 44.27%189K | --0 | --0 | -93.40%19K |
| -Long term capital lease obligation | -13.17%145K | 19.05%225K | --303K | --303K | 652.63%143K | 122.67%167K | 44.27%189K | --0 | --0 | -93.40%19K |
| Total non current liabilities | -0.36%6.15M | 0.58%6.23M | 5.05%6.3M | 5.05%6.3M | 2.06%6.14M | 1.51%6.17M | 0.95%6.19M | -3.30%6M | -3.30%6M | -4.28%6.02M |
| Total liabilities | -12.84%11.08M | -5.06%10.64M | 4.92%13.33M | 4.92%13.33M | 6.58%12.26M | 16.55%12.71M | -1.47%11.21M | 12.11%12.71M | 12.11%12.71M | -6.80%11.5M |
| Shareholders'equity | ||||||||||
| Share capital | 1.25%81K | 0.00%81K | -1.22%81K | -1.22%81K | -4.82%79K | -3.61%80K | -2.41%81K | -1.20%82K | -1.20%82K | 0.00%83K |
| -common stock | 1.25%81K | 0.00%81K | -1.22%81K | -1.22%81K | -4.82%79K | -3.61%80K | -2.41%81K | -1.20%82K | -1.20%82K | 0.00%83K |
| -Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | -24.87%-179.51M | -27.54%-171.96M | -26.70%-161.52M | -26.70%-161.52M | -27.53%-152.06M | -28.37%-143.76M | -29.47%-134.83M | -32.21%-127.48M | -32.21%-127.48M | -31.35%-119.24M |
| Paid-in capital | 1.27%189.92M | 1.10%189.52M | 0.95%188.94M | 0.95%188.94M | 0.34%187.67M | 0.50%187.54M | 0.78%187.45M | 0.94%187.16M | 0.94%187.16M | 1.13%187.03M |
| Less: Treasury stock | 13.37%212K | 15.52%201K | 15.29%196K | 15.29%196K | 15.29%196K | 23.84%187K | 46.22%174K | 49.12%170K | 49.12%170K | 49.12%170K |
| Gains losses not affecting retained earnings | --0 | ---- | --0 | --0 | ---4K | ---11K | ---5K | ---9K | ---9K | ---- |
| Total stockholders'equity | -76.47%10.28M | -66.79%17.44M | -54.17%27.31M | -54.17%27.31M | -47.58%35.49M | -41.43%43.66M | -35.81%52.52M | -33.03%59.58M | -33.03%59.58M | -28.07%67.71M |
| Total equity | -76.47%10.28M | -66.79%17.44M | -54.17%27.31M | -54.17%27.31M | -47.58%35.49M | -41.43%43.66M | -35.81%52.52M | -33.03%59.58M | -33.03%59.58M | -28.07%67.71M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data